ACCESS Newswire

/ Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (“LOI”) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.

/ PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s

Latest News

– Global registrations of battery-electric vehicles rose 12% in the first nine months of 2026 to a record 11 million, driven by strong growth in Europe, according to a study by consultancy PwC. Europe accounted for 2.5 million electric cars,